NCT06044792View on ClinicalTrials.gov

The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

January 1, 2028

Conditions
HivAIDSCD4 DeficiencyARTTreatment Resistant DisordersTreatment-Sensitive HIV Infection
Interventions
OTHER

differences in CD4 reconstruction

Differences in the increase in CD4 lymphocyte count and CD4:CD8 ratio between patients with primary drug resistance mutations and those without these mutations.

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH | Biotech Hunter | Biotech Hunter